<DOC>
	<DOCNO>NCT01457430</DOCNO>
	<brief_summary>The investigator propose study evaluate safety , local tolerability , convenience , efficacy self-administered Icatibant treatment acute attack hereditary angioedema . The investigator believe self administration Icatibant treatment acute attack angioedema change time complete near complete resolution symptom compare treatment Icatibant medical facility .</brief_summary>
	<brief_title>Efficacy , Safety Tolerability Icatibant Treatment HAE</brief_title>
	<detailed_description />
	<mesh_term>Angioedema</mesh_term>
	<mesh_term>Angioedemas , Hereditary</mesh_term>
	<mesh_term>Icatibant</mesh_term>
	<mesh_term>Bradykinin</mesh_term>
	<criteria>1 . Males female least 18 year age time inform consent 2 . Documented diagnosis hereditary angioedema Type I II base ALL follow criterion : Family and/or medical history Characteristic attack manifestation , recurrent attack Historical low C4 , normal C1q either low C1INH low C1INH function 3 . Women childbearing potential must use consistently correctly highly effective , adequate method birth control ( failure rate le 1 % per year ) , sexual abstinence vasectomise partner duration study . Hormonal contraception continue verified physician n't affect course hereditary angioedema attack . 4 . Mental physical condition allow patient complete baseline assessment , selfadminister Icatibant follow study procedure . 5 . Ability provide sign write informed consent aspect study explain discussed patient . 1 . Participation clinical therapeutic trial another investigational medicinal product within past month ( except previous Icatibant study ) . 2 . Diagnosis angioedema Type I Type II hereditary angioedema . 3 . Evidence symptomatic coronary artery disease base medical history , particular , unstable angina pectoris severe coronary heart disease . 4 . Congestive heart failure ( NYHA Class 3 4 ) . 5 . Stroke within past 6 month . 6 . Treatment angiotensin convert enzyme inhibitor . 7 . Pregnancy and/or breastfeed . 8 . In opinion investigator : mental condition render patient unable understand nature , scope possible consequence study . 9 . In opinion investigator : unlikely comply protocol , example , uncooperative attitude , inability return followup visit , unlikely complete study reason . 10 . In opinion investigator : inability complete patient diary , manage study medication selfadministration injection .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>